Overview

Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care

Status:
Terminated
Trial end date:
2002-07-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care
Details
Lead Sponsor:
University Hospital, Geneva
Treatments:
Nadroparin